Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17400799rdf:typepubmed:Citationlld:pubmed
pubmed-article:17400799lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:17400799lifeskim:mentionsumls-concept:C0014272lld:lifeskim
pubmed-article:17400799lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:17400799lifeskim:mentionsumls-concept:C0034843lld:lifeskim
pubmed-article:17400799lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:17400799lifeskim:mentionsumls-concept:C1135764lld:lifeskim
pubmed-article:17400799lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:17400799pubmed:issue1lld:pubmed
pubmed-article:17400799pubmed:dateCreated2007-4-2lld:pubmed
pubmed-article:17400799pubmed:abstractTextIt is well known that thyroid hormone affects body composition; however, the effect of the thyroid hormone receptor beta (TRbeta)-selective thyromimetic GC-1 on this biological feature had not been demonstrated. In the current study, we compared the effects of a 6-week treatment with triiodothyronine (T3; daily injections of 3 or 6 microg/100 g body weight) or GC-1 (equimolar doses) on different metabolic parameters in adult female rats. Whereas all animals gained weight (17-25 g) in a way not basically affected by T3 or GC-1 treatment, only T3 treatment selectively increased food intake (50-70%). Oxygen consumption was significantly and equally increased (50-70%) by T3 and GC-1. Analysis of body composition by dual-energy X-ray absorptiometry (DEXA) revealed that, whereas control animals gained about 80% of fat mass, T3- or GC-1-treated animals lost 70-90 and approximately 20% respectively. Direct analysis of the carcass showed that T3 treatment promoted a 14-74% decrease in fat content but GC-1 treatment promoted only a 15-23% reduction. The gain in lean mass by DEXA and the carcass protein content were not affected by T3 or GC-1 treatment. However, the mass of individual skeletal muscles was negatively affected by T3 but only barely by GC-1. These findings highlight the potential use of GC-1 for the treatment of obesity and the metabolic syndrome.lld:pubmed
pubmed-article:17400799pubmed:languageenglld:pubmed
pubmed-article:17400799pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17400799pubmed:citationSubsetIMlld:pubmed
pubmed-article:17400799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17400799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17400799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17400799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17400799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17400799pubmed:statusMEDLINElld:pubmed
pubmed-article:17400799pubmed:monthAprlld:pubmed
pubmed-article:17400799pubmed:issn0022-0795lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:ScanlanThomas...lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:BiancoAntonio...lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:FreitasFatima...lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:MoriscotAnsel...lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:AokiMarcelo...lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:RibeiroMiriam...lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:GouveiaCecíli...lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:VillicevCássi...lld:pubmed
pubmed-article:17400799pubmed:authorpubmed-author:TaffarelCássi...lld:pubmed
pubmed-article:17400799pubmed:issnTypePrintlld:pubmed
pubmed-article:17400799pubmed:volume193lld:pubmed
pubmed-article:17400799pubmed:ownerNLMlld:pubmed
pubmed-article:17400799pubmed:authorsCompleteYlld:pubmed
pubmed-article:17400799pubmed:pagination21-9lld:pubmed
pubmed-article:17400799pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:meshHeadingpubmed-meshheading:17400799...lld:pubmed
pubmed-article:17400799pubmed:year2007lld:pubmed
pubmed-article:17400799pubmed:articleTitleThyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats.lld:pubmed
pubmed-article:17400799pubmed:affiliationDepartment of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof Lineu Prestes, 2415 Sao Paulo 05508-900, Brazil.lld:pubmed
pubmed-article:17400799pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17400799pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:17400799pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17400799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17400799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17400799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17400799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17400799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17400799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17400799lld:pubmed